ALZN vs RYDE
Comparison between Alzamend Neuro Inc (ALZN, Company) and Ryde Group Ltd - Class A (RYDE, Company).
ALZN is from the Healthcare sector, while RYDE is from the Technology sector.
ALZN vs RYDE - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
Market Cap
ALZN
$4.64M
Winner
RYDE
$4.70M
Max Drawdown
ALZN
100.00%
Winner
RYDE
99.14%
Sharpe Ratio
ALZN
-0.84
Winner
RYDE
1.40
5Y Beta
Winner
ALZN
0.00
RYDE
0.81
Industry
ALZN
Biotechnology
RYDE
Software - Application
P/E Ratio
Winner
ALZN
-0.39
RYDE
-0.34
Debt to Equity
ALZN
0.00%
RYDE
0.00%
P/S Ratio
ALZN
N/A
RYDE
2.89
P/B Ratio
ALZN
N/A
RYDE
4.53
ALZN vs RYDE - Historical Returns
Returns include dividend reinvestment.
1M
Winner
ALZN
+19.61%
RYDE
-25.10%
3M
ALZN
-36.46%
Winner
RYDE
+10.18%
6M
ALZN
-43.52%
Winner
RYDE
+97.31%
1Y
ALZN
-59.60%
Winner
RYDE
+63.11%
5Y(CAGR)
ALZN
-84.15%
RYDE
N/A
Max(CAGR)
ALZN
-85.33%
Winner
RYDE
-52.41%
ALZN vs RYDE - Annual Returns (2021 - 2026)
Returns include dividend reinvestment.
| Year | ALZN | RYDE |
|---|---|---|
| 2026 | -35.79% | +185.05% |
| 2025 | -83.15% | -48.51% |
| 2024 | -87.39% | -88.50% |
| 2023 | -89.77% | N/A |
| 2022 | -71.90% | N/A |
| 2021 | -85.93% | N/A |
ALZN vs RYDE Drawdown Comparison
The maximum drawdown for ALZN was -100.00%, occurring on Apr 10, 2026. This drawdown has not yet recovered.
The maximum drawdown for RYDE was -99.14%, occurring on Jun 17, 2025. This drawdown has not yet recovered.
The current ALZN drawdown is -99.99%. The current RYDE drawdown is -96.40%.
| Rank | ALZN | RYDE |
|---|---|---|
| #1 | -100.00% Jun 15, 2021 - Apr 10, 2026 | -99.14% Sep 10, 2024 - Jun 17, 2025 |
| #2 | N/A | -68.82% Mar 11, 2024 - May 8, 2024 |
| #3 | N/A | -58.15% May 24, 2024 - Sep 5, 2024 |
| #4 | N/A | -17.04% May 9, 2024 - May 24, 2024 |
Correlation
Correlation between ALZN and RYDE is 0.68 which considered as a moderate positive correlation - the stocks show some tendency to move together.
0.68
-101
Select Stocks to Compare
Popular: ALZN vs SPYRYDE vs SPY
More Comparisons
Compare with similar stocks